Drug
Rgh 896
Rgh 896: highest development phase Phase 2, developed by Gedeon Richter. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| RGH-896 NCT00838799 | Phase 2 | Diabetic Peripheral Neuropathic Pain |
Latest
No recent events.
Follow Rgh 896 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.